======= SLC9B2 ======= == Gene Information == * **Official Symbol**: SLC9B2 * **Official Name**: solute carrier family 9 member B2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=133308|133308]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q86UD5|Q86UD5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC9B2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC9B2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611789|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Na(+)/H(+) antiporter that extrudes Na(+) or Li(+) in exchange for external protons across the membrane (PubMed:18000046, PubMed:28154142, PubMed:22948142, PubMed:18508966). Contributes to the regulation of intracellular pH, sodium homeostasis, and cell volume. Plays an important role for insulin secretion and clathrin-mediated endocytosis in beta- cells (By similarity). Involved in sperm motility and fertility (By similarity). It is controversial whether SLC9B2 plays a role in osteoclast differentiation or not (By similarity). {ECO:0000250|UniProtKB:Q5BKR2, ECO:0000269|PubMed:18000046, ECO:0000269|PubMed:18508966, ECO:0000269|PubMed:22948142, ECO:0000269|PubMed:28154142}. |Na H Exchanger| |monovalent cation:proton antiporter activity| |lithium:proton antiporter activity| |positive regulation of osteoclast development| |positive regulation of bone development| |regulation of osteoclast development| |sodium:proton antiporter activity| |sperm principal piece| |regulation of bone development| |clathrin-dependent endocytosis| |positive regulation of osteoclast differentiation| |positive regulation of myeloid leukocyte differentiation| |regulation of insulin secretion involved in cellular response to glucose stimulus| |regulation of osteoclast differentiation| |synaptic vesicle membrane| |sperm motility| |flagellated sperm motility| |sodium ion transmembrane transport| |positive regulation of myeloid cell differentiation| |cilium or flagellum-dependent cell motility| |cilium-dependent cell motility| |mitochondrial membrane| |regulation of myeloid leukocyte differentiation| |proton transmembrane transport| |positive regulation of leukocyte differentiation| |sodium ion transport| |regulation of insulin secretion| |positive regulation of hemopoiesis| |basolateral plasma membrane| |regulation of peptide hormone secretion| |endosome membrane| |regulation of myeloid cell differentiation| |receptor-mediated endocytosis| |regulation of hormone secretion| |regulation of leukocyte differentiation| |apical plasma membrane| |mitochondrial inner membrane| |monovalent inorganic cation transport| |regulation of hemopoiesis| |regulation of protein secretion| |regulation of peptide secretion| |regulation of hormone levels| |positive regulation of cell development| |cell junction| |endocytosis| |inorganic cation transmembrane transport| |cation transmembrane transport| |metal ion transport| |inorganic ion transmembrane transport| |import into cell| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |regulation of secretion by cell| |regulation of secretion| |cation transport| |regulation of cellular localization| |regulation of cell development| |ion transmembrane transport| |positive regulation of cell differentiation| |regulation of protein localization| |identical protein binding| |localization of cell| |cell motility| |positive regulation of immune system process| |transmembrane transport| |locomotion| |positive regulation of developmental process| |ion transport| |reproductive process| |reproduction| |movement of cell or subcellular component| |regulation of immune system process| |positive regulation of multicellular organismal process| |regulation of cell differentiation| |regulation of transport| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.82| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10367 * **Expression level (log2 read counts)**: 4.87 {{:chemogenomics:nalm6 dist.png?nolink |}}